[
  {
    "ts": null,
    "headline": "Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel",
    "summary": "TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.",
    "url": "https://finnhub.io/api/news?id=e26d0b7fbc26f8c8a7ec93580c9f226050ba643ccb53eebbd0c2bbdcdd5d15d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771345200,
      "headline": "Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel",
      "id": 139125135,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.",
      "url": "https://finnhub.io/api/news?id=e26d0b7fbc26f8c8a7ec93580c9f226050ba643ccb53eebbd0c2bbdcdd5d15d6"
    }
  },
  {
    "ts": null,
    "headline": "QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement",
    "summary": "QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.",
    "url": "https://finnhub.io/api/news?id=c6d9d7b79b511bb61173e85c2d03c75130cc43c31db90ab9e7e8523646366129",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771344720,
      "headline": "QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement",
      "id": 139125136,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.",
      "url": "https://finnhub.io/api/news?id=c6d9d7b79b511bb61173e85c2d03c75130cc43c31db90ab9e7e8523646366129"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Posts Better-Than-Expected Earnings. Here’s Why the Stock Is Falling.",
    "summary": "Medical device maker  Medtronic  reported quarterly earnings and net sales that topped consensus views.  Medtronic  on Tuesday posted fiscal third-quarter adjusted earnings of $1.36 a share, narrowly beating analysts’ forecasts of $1.34.  Medtronic’s profit declined from the same period last year on a non-adjusted basis, slipping to $1.14 billion from $1.29 billion.",
    "url": "https://finnhub.io/api/news?id=049986bb1794b0e6318935b32003f3cb30bcf9a167c7c7fd90bfea295927eeeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771333200,
      "headline": "Medtronic Posts Better-Than-Expected Earnings. Here’s Why the Stock Is Falling.",
      "id": 139122218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Medical device maker  Medtronic  reported quarterly earnings and net sales that topped consensus views.  Medtronic  on Tuesday posted fiscal third-quarter adjusted earnings of $1.36 a share, narrowly beating analysts’ forecasts of $1.34.  Medtronic’s profit declined from the same period last year on a non-adjusted basis, slipping to $1.14 billion from $1.29 billion.",
      "url": "https://finnhub.io/api/news?id=049986bb1794b0e6318935b32003f3cb30bcf9a167c7c7fd90bfea295927eeeb"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=ecf92ea0b42612cde1af0597d071ac176201768a7bbb553b8b03c61d573dcfcb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771336803,
      "headline": "Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know",
      "id": 139124044,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=ecf92ea0b42612cde1af0597d071ac176201768a7bbb553b8b03c61d573dcfcb"
    }
  },
  {
    "ts": null,
    "headline": "What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?",
    "summary": "Although Intuitive Surgical has lagged the broader market over the past year, analysts remain broadly bullish on the company’s long-term growth outlook.",
    "url": "https://finnhub.io/api/news?id=7549860379b1d2e1514f3378dc2f3e23b34d7b44aabb495cad46e1bc66786eda",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771317197,
      "headline": "What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?",
      "id": 139121316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Although Intuitive Surgical has lagged the broader market over the past year, analysts remain broadly bullish on the company’s long-term growth outlook.",
      "url": "https://finnhub.io/api/news?id=7549860379b1d2e1514f3378dc2f3e23b34d7b44aabb495cad46e1bc66786eda"
    }
  }
]